Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers
about
Vaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalInfluenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveInfluenza vaccination in immunocompromised patients: efficacy and safety.Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season.Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients.An audit of influenza and pneumococcal vaccination in rheumatology outpatients.Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.Vaccinations in patients with immune-mediated inflammatory diseasesA practical approach to monitoring patients on biological agents for the treatment of psoriasis2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Vaccinations for rheumatoid arthritis.Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: results of an open-label, parallel group, randomized, single-center study.Update of the management of chronic psoriasis: new approaches and emerging treatment options.Serious infections with antirheumatic therapy: are biologicals worse?Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.The safety of etanercept for the treatment of plaque psoriasis.The observation of humoral responses after influenza vaccination in patients with rheumatoid arthritis treated with Japanese oriental (kampo) medicine: an observational study.Should children under treatment for juvenile idiopathic arthritis receive flu vaccination?Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis.Rituximab-treated patients have a poor response to influenza vaccinationImpact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis.Tumor necrosis factor inhibitors and infection complications.Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report.Update on the natural history and systemic treatment of psoriasis.Vaccination in patients with chronic rheumatic or autoimmune diseases.Immunizations in patients with inflammatory bowel disease.Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics.Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.Are anti-infectious vaccinations safe and effective in patients with autoimmunity?A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Vaccination against infection in patients with multiple sclerosis.Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.Vaccines and biologics.Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases.Vaccination of patients with autoimmune inflammatory rheumatic diseases.
P2860
Q26749096-9141936C-88CF-480F-BC76-E26F23E0884BQ28740919-F8D98B4F-959E-463F-99AA-9C6F9EF81086Q30358640-2E4F355A-4EB8-4C11-B088-739D3482A34AQ30397819-F1964916-8FD9-4576-865C-12D071C04172Q30400508-A8E37FE2-8E1C-40DB-9C8A-DB4521560C1BQ30401020-6BC54E06-0377-4323-B67D-B828BF5BA96AQ30406587-8C5D6C1D-89AC-4EEA-A4BC-1963A8169C5FQ30417659-36F8163B-B8CE-4C08-A4B0-3D326A7F133FQ30420493-3C0BBE49-4C09-4006-86E4-FBEC4BDE8784Q33289919-06723891-FF41-40FE-8CEA-DDD027F8EE5EQ34027585-3B6CCEC4-6EF8-47F2-8106-341922D44D88Q34117134-17B73F1D-E635-4642-BC1E-8954D15C87C5Q34156420-C48DCEA1-4AC5-4253-8ACB-E279041BD777Q34390072-840586DD-467F-41FD-81EF-D19324AF22ACQ34424563-330FE689-9924-4E52-A7E2-2F845C732D47Q34431953-C0C3706F-4A9F-4F7A-9222-0455C6EBE6F5Q34620375-0E79B17F-FCF6-45E6-B443-858F5F1F0432Q35638259-0002B5DA-6443-43EA-9575-79FE7F99AA3AQ35907835-991736A4-D5B3-4490-B91F-849079D19B3EQ35919214-CC4F5871-363A-402E-801E-0517B83096B7Q35942685-990AED5A-B216-49A9-AC26-CEE83D38EF05Q36155286-40AA861A-D42C-418A-B78E-4DD78584621EQ36171750-09E29C84-44E7-414A-B2A3-F145D92C9D66Q36367842-390B3505-0E32-4632-8314-4F14468508C1Q36589247-4AED613F-594D-4014-A4D0-2B1D9D8DFE4AQ36679769-E9BEB022-253A-4A2E-8123-3A7D81CAE4E6Q36806922-CBF8DE67-EB80-4D7D-AD52-5B5D898752A0Q36826300-5DE42DFE-A8BC-415E-8402-2ABFA6ADB9AAQ37081486-D404C745-2954-48F6-8591-9E7BD28AA381Q37141193-9FC47209-4CB2-48EB-97AC-35ACEC00F133Q37466464-E5FC45EE-57CC-487E-9CC9-EB86466D9D24Q37492480-FC4E7D6E-DBA8-49C7-AD12-A7085FB93B61Q37669457-36D52DA2-8D1F-410A-BFAB-43C48E5B785DQ37762551-D6776749-374E-4508-99BD-3FA315567C76Q37814549-B232F069-96E6-498E-AFD4-6E679F956634Q37978121-69B8567D-6FE9-4C61-A271-27CA9B3F72FBQ38171461-88A4EBB0-7FFD-4759-8F6C-0F40BC42E702Q38213192-425BED36-CD79-47FA-A0DE-73CB5DC9B080Q38266287-C24FAC86-5BD3-40A2-AEE1-8A4D7D840B9BQ38285275-51B71016-1F8F-4ACB-8735-C01E52D5D7DF
P2860
Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vaccination against influenza ...... , including TNF alpha blockers
@ast
Vaccination against influenza ...... , including TNF alpha blockers
@en
type
label
Vaccination against influenza ...... , including TNF alpha blockers
@ast
Vaccination against influenza ...... , including TNF alpha blockers
@en
prefLabel
Vaccination against influenza ...... , including TNF alpha blockers
@ast
Vaccination against influenza ...... , including TNF alpha blockers
@en
P2093
P2860
P356
P1476
Vaccination against influenza ...... , including TNF alpha blockers
@en
P2093
D Levartovsky
E Mendelson
I Litinsky
P2860
P304
P356
10.1136/ARD.2005.036434
P407
P577
2005-07-13T00:00:00Z